Menu
  • Welcome
  • Resources
  • Webinars
  • News
  • Stats
  • Forums
  • Team
  • Contact
  • My Account
  • FR
  • Welcome
  • Resources
  • Webinars
  • News
  • Stats
  • Forums
  • Team
  • Contact
  • My Account
  • FR
home/Knowledge Base/Respirology

Potential Effect of Complement Pathways in Thrombotic Microvascular Injury

26 views 0 05/22/2020 Audrey Mathieu

  1. Based on pulmonary and cutaneous biopsy and autopsy samples, some critically ill patients present a generalized thrombotic microvascular injury.
  2. Cutaneous manifestation consistent with a thrombotic microvascular injury included retiform purpura or livedo racemose.
  3. Histological findings suggest that some of the severe cases of COVID-19 would have thrombotic injuries mediated by a systemic activation of the alternative and lectin-based complement pathways.
    • Important deposits of terminal complement complex C5b-9, C4d, and MASP2 in the microvasculature of lungs, normal-appearing skin and retiform cutaneous lesions.
    • Paucicellular terminal lung parenchymal injury with septal capillary damage.
  4. These histological findings could be associated with an increase in dead space fraction, resulting in respiratory failure with high lung compliance and less lung consolidation than typical ARDS. This supports the fact that COVID-19 gives a different respiratory outcome than typical ARDS.
  5. Inhibitors of the alternative or lectin complement pathways (e.g. narsoplimab, eculizumab) may be useful in some severe cases of COVID-19 with suspected generalized thrombotic microvascular
  6. Skin biopsy, if easily accessible, might be a interesting tool to include with other laboratory testing (D-dimers, factor VIII, fibrinogen, other coagulation factors, antiphospholipid antibodies, CRP, pro-inflammatory cytokines (IL-1, IL-6), complement proteins (C3, C4, C5b-9, Bb)) for establishing criteria for specific anticomplement or anticoagulation therapy in critically ill patient.

 

Magro C. et al. studied skin and lung tissues from 5 critically ill patients with COVID-19 defined by respiratory failure and purpuric skin rash.

 

Source :

  1. Magro C., Mulvey J.J., Berlin D. et al (April 9, 2020). Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Translational Research. https://doi.org/10.1016/j.trsl.2020.04.007
Tags:Complement PathwaysThrombotic Microvascular InjuryRetiform PurpuraLivedo Racemoselung biopsynarsoplimabeculizumabskin biopsy

Was this helpful?

Yes  No
Related Articles
  • The Use of Corticosteroids in Adrenal Insufficiency
  • ILDS / AAD Registry : a case series on pernio-like skin lesions
  • Treatment simulation for Health Care Providers: Managing Suspected and Confirmed cases
  • Guidelines: Aesthetic Clinic Reopening
  • Thrombotic occlusive vasculopathy
  • An Update on the Management of Patients with Pernio-like Lesions
Respirology
  • Potential Effect of Complement Pathways in Thrombotic Microvascular Injury
  • Presentation and evolution of positive COPD patients
  • Outpatient Management of COPD
  • Ventilation phenotypes specific considerations
  • Impact on Patients with Cystic Fibrosis
  • Management of Asthmatic Patients
View All 17  
Popular Articles
  • Acute Acro-Ischemic Lesions in Children
  • Insights About Reinfection and Immunization
  • What Is the Efficacy of Masks in Preventing Transmission?
  • Rationale of Old Antimalarial Drugs Against New Pandemic
  • PPE requirement for Aerosol Generating Medical Procedures
Specialties
  • Endocrinology
  • Anesthesiology
  • Cardiology
  • Dental Surgery
  • Dermatology
  • Emergency Medicine
  • ENT
  • Geriatrics and Palliative Care
  • Gastroenterology
  • Hematology
  • Infectious Diseases
  • Intensive Care
  • Neurology
  • OB-GYN
  • Oncology
  • Ophthalmology
  • Pediatrics
  • Pharmacology
  • Preventive Medicine
  • Protection of Healthcare Workers
  • Psychiatry
  • Public health
  • Other Internal Medicine Specialties
  • Radiology
  • Respirology
  • Stages of COVID-19 Infection
    • Presumption & Prevention
    • Screening & Diagnosis
    • Mild Infection
    • Moderate Infection
    • Severe Infection
    • Outcomes
  • Surgery
About How I Treat COVID-19

Our website is dedicated to helping healthcare professionals find accurate and up-to-date information about the best ways to manage and treat patients affected by the COVID-19 outbreak.

Navigation
  • Resources
  • News
  • Webinars
  • Forum
Useful Links
  • COVID-19 Protocols
  • Health Canada
  • WHO
  • CDC
Practice

  • Privacy Policy
  • Terms & Conditions
  • How I Treat Covid-19 © 2020 Made with ♥ by Mondien